BioAge Labs Inc. (BIOA) vs MacroGenics, Inc. (MGNX)
A side-by-side comparison of BioAge Labs Inc. and MacroGenics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIOA
BioAge Labs Inc.
$6.13HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
MGNX
MacroGenics, Inc.
$3.61HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Total return — BIOA vs MGNX
growth of $100 · dividends reinvested · last 2yBIOA -65.3% (-41.1%/yr)MGNX +25.7% (+12.1%/yr)MGNX compounded faster over this window
BIOA MGNX
BIOA vs MGNX: by the numbers
- •BIOA is the larger company ($231M vs $229M market cap).
- •Both run net losses; MGNX's is the smaller (-8.70% vs -912.25% net margin).
Metrics side by side
Valuation
| Metric | BIOA | MGNX |
|---|---|---|
| P/S ratio | 22.29 | 1.37 |
| P/B ratio | 0.62 | 5.35 |
Profitability
| Metric | BIOA | MGNX |
|---|---|---|
| Gross margin | 99.39% | 71.12% |
| Operating margin | -1026.28% | -48.72% |
| Net margin | -912.25% | -8.70% |
| ROE | -25.20% | -34.04% |
| ROIC | -28.14% | -16.87% |
Growth (annualized)
| Metric | BIOA | MGNX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.33% |
| Total return CAGR (5Y) | N/A | -28.42% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.